<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: The role of <z:chebi fb="67" ids="50114">oestrogen</z:chebi> metabolism and action in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) is controversial </plain></SENT>
<SENT sid="1" pm="."><plain>An extensive review of the current literature, encompassing epidemiological evidence, systemic and peripheral <z:chebi fb="67" ids="50114">oestrogen</z:chebi> concentrations, 17β-<z:chebi fb="0" ids="35350">hydroxysteroid</z:chebi> dehydrogenase (17β-HSD) and aromatase in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, steroid sulphatase (STS)/<z:chebi fb="1" ids="17263">oestrone</z:chebi> sulphotransferase (EST) and in vitro and in vivo genomic effects was therefore undertaken </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: A literature search (key words: <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, <z:chebi fb="67" ids="50114">oestrogen</z:chebi>, <z:chebi fb="67" ids="50114">oestrogen</z:chebi> receptor, 17β-HSD, STS, <z:chebi fb="0" ids="25696">organic anion</z:chebi> transporter) was performed using Embase, Medline, and Pubmed and papers were evaluated on scientific relevance on an individual basis </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Epidemiological data highlights that premenopausal women, or postmenopausal women taking hormone replacement therapy, are significantly less likely than males to develop <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>This implies that <z:chebi fb="67" ids="50114">oestrogen</z:chebi> signalling is most likely involved in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> <z:mp ids='MP_0001532'>physiology</z:mp> and aetiology </plain></SENT>
<SENT sid="5" pm="."><plain>Little is known about <z:chebi fb="67" ids="50114">oestrogen</z:chebi> metabolism in the colon </plain></SENT>
<SENT sid="6" pm="."><plain>However, the expression of 17β-HSD, STS, and EST, enzymes involved in <z:chebi fb="67" ids="50114">oestrogen</z:chebi> metabolism, have shown prognostic significance </plain></SENT>
<SENT sid="7" pm="."><plain>Evidence also suggests that protective effects are modulated through <z:chebi fb="67" ids="50114">oestrogen</z:chebi> receptor beta, although which metabolite of <z:chebi fb="67" ids="50114">oestrogen</z:chebi>, <z:chebi fb="0" ids="23965">oestradiol</z:chebi> (E(2)) or <z:chebi fb="1" ids="17263">oestrone</z:chebi> (E(1)), is more active remains undefined </plain></SENT>
<SENT sid="8" pm="."><plain>To complicate matters, the changes in the peripheral ratios of these enzymes, <z:chebi fb="2" ids="50114">oestrogens</z:chebi> and receptors most likely influences <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> progression </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Epidemiological evidence, now supported by in vitro and in vivo studies, strongly associates <z:chebi fb="67" ids="50114">oestrogen</z:chebi> action and metabolism with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Initially protective against <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, once developed, results suggests that <z:chebi fb="2" ids="50114">oestrogens</z:chebi> increase proliferation </plain></SENT>
<SENT sid="11" pm="."><plain>Consequently, hormone-ablation therapy, already successful against breast and <z:hpo ids='HP_0012125'>prostate cancer</z:hpo>, may be effective against <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>